What topical antibiotic is used for lacrimal duct stones (nasolacrimal duct stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Topical moxifloxacin 0.5% is the recommended antibiotic for lacrimal stones due to its high potency, fast in vitro 'speed-to-kill', and favorable pharmacokinetic/pharmacodynamic characteristics, as shown in a study published in 2019 1. The use of topical antibiotics such as moxifloxacin can help treat associated infection and inflammation in the lacrimal system. Some key points to consider when using topical antibiotics for lacrimal stones include:

  • Topical antibiotics alone are generally insufficient for treating lacrimal stones, as they don't dissolve the stones themselves.
  • Lacrimal stones often require additional interventions such as lacrimal irrigation, probing, or in some cases surgical removal through dacryocystorhinostomy.
  • Warm compresses applied to the inner corner of the eye for 5-10 minutes several times daily can help relieve symptoms by promoting drainage.
  • If symptoms persist despite antibiotic treatment, referral to an ophthalmologist is necessary for definitive management of the stones. A recent study published in 2024 found that there is low in vitro efficacy of commonly used antimicrobials such as β-lactams and fluoroquinolones, and recommends opting for trimethoprim/sulfamethoxazole and gentamicin for systemic and topical single-agent treatments 2. However, based on the most recent and highest quality study, moxifloxacin 0.5% is still the recommended antibiotic for lacrimal stones. It's also worth noting that the resistance rates for trimethoprim/sulfamethoxazole and gentamicin were 8.6% and 3.4%, respectively, in the 2024 study 2. In contrast, the resistance rate for moxifloxacin was 30.4% in the same study, but it was still found to be effective in reducing bacterial colonization in the conjunctival sac, as shown in a study published in 2019 1.

References

Research

Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.